Vietnam Neurovascular Devices Market, By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices), By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others), By End User (Hospitals, Specialty Clinics, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Vietnam Neurovascular Devices Market was valued at USD 135.12 Million in 2024 and is expected to reach USD 198.51 Million by 2030 with a CAGR of 6.58%. The Vietnam Neurovascular Devices Market is experiencing dynamic growth, propelled by an increasing neurovascular disease burden, shifting clinical protocols, and a healthcare system undergoing structural modernization. With stroke now the leading cause of death and long-term disability in the country, demand for cutting-edge neurointerventional solutions is rising sharply. This evolving landscape is positioning Vietnam as a strategic destination for global manufacturers and distributors seeking to penetrate high-growth emerging markets.

As of 2021, Vietnam had an estimated population of 98.32 million, with a demographic profile largely dominated by a young population base. However, the aging segment of individuals aged 65 and older accounted for approximately 7.7% of the total population, signaling a gradual demographic shift, escalating stroke incidence, and targeted government investment in stroke care infrastructure, the market is set on a robust growth trajectory. As Vietnam’s public health agenda prioritizes access to minimally invasive, high-efficacy treatment modalities, the neurovascular devices sector offers compelling opportunities for innovation, market entry, and long-term value creation across both public and private healthcare channels.

Key Market Drivers

Rising Incidence of Neurovascular Disorders—Particularly Stroke

The increasing prevalence of neurovascular disorders, particularly stroke, is one of the most powerful catalysts driving the growth of the Vietnam Neurovascular Devices Market. Stroke represents the primary cause of both mortality and long-term disability in Vietnam, posing a significant public health and economic burden. According to reported data, the country faces an incidence rate of 161 new stroke cases and a prevalence rate of 415 existing cases per 100,000 population highlighting the urgent demand for timely intervention and advanced neurovascular care solutions. The disease burden is rising rapidly due to aging demographics, lifestyle-related risk factors (such as hypertension, obesity, diabetes, and smoking), and delayed diagnosis in many rural areas. Vietnam continues to face a substantial burden from ischemic stroke, which ranks among the country's leading causes of death and long-term disability. In 2021 alone, stroke accounted for 166,954 fatalities nationwide. The condition demonstrated a high incidence rate of 222 cases per 100,000 population, while the prevalence reached 1,541 per 100,000 reflecting a critical and growing need for scalable stroke management solutions and advanced neurovascular interventions within the country’s healthcare infrastructure. Hemorrhagic stroke cases are creating a need for aneurysm coiling systems, embolic agents, and flow-diverting stents, particularly in tertiary care centers. As the number of stroke patients continues to grow, device utilization rates in neurointerventional procedures are rising, particularly in urban hospitals equipped to handle such emergencies.

Stroke is a time-critical condition, with patient outcomes heavily dependent on how quickly blood flow to the brain can be restored. This creates a clinical imperative to adopt fast, effective intervention tools, boosting reliance on cutting-edge neurovascular devices. Hospitals are under pressure to shorten door-to-needle and door-to-groin times, encouraging the use of devices that support rapid clot removal and minimal procedural complexity. Increasing focus on the “golden hour” in stroke treatment is fueling investment in catheter-based technologies, diagnostic imaging, and supportive devices. This urgency is compelling hospitals to upgrade their neurointerventional capabilities, leading to higher capital and consumable spending on neurovascular product lines. In response to the growing stroke burden, Vietnam's Ministry of Health is working to establish more stroke-ready hospitals across key urban and provincial centers. These facilities require trained personnel and essential neurovascular equipment. Expanded infrastructure is directly increasing the number of centers capable of performing neurointerventional stroke treatment, thereby expanding the addressable market for device suppliers. Standardized clinical pathways for acute stroke care are encouraging routine use of thrombectomy and embolization devices as part of the treatment algorithm. Device manufacturers benefit from institutional demand and predictable procurement patterns, especially as stroke care protocols become more widespread and standardized across Vietnam.

Supportive Government Policies and Health Initiatives

The Vietnam Neurovascular Devices Market is experiencing robust growth, significantly bolstered by government-led reforms and national health initiatives aimed at modernizing the country’s healthcare system. These policies are particularly impactful in promoting neurological disease management, improving access to advanced treatment technologies, and strengthening stroke care capacity across public and private healthcare facilities. As a result, the government’s involvement is emerging as a critical driver of device adoption and market expansion. Recognizing the growing burden of stroke Vietnam’s second leading cause of death the Ministry of Health (MoH) has elevated stroke care to the national health agenda, aligning with global efforts to reduce disability and mortality rates. The government is encouraging hospitals to adopt standardized stroke protocols, including the use of endovascular thrombectomy and aneurysm coiling, which directly increases demand for neurovascular devices. National stroke awareness campaigns are leading to earlier patient presentation and higher volumes of treatable cases, which in turn supports higher device usage rates. Bayer Vietnam and the Medical Services Administration (MSA) under Vietnam’s Ministry of Health formalized a strategic communication initiative aimed at enhancing public awareness around stroke prevention. The partnership, spanning the 2021–2023 period, focuses on delivering targeted educational campaigns and community engagement programs to reduce stroke risk and promote early intervention across Vietnam. This collaboration underscores a shared commitment to improving health literacy and supporting national efforts to address the country’s growing stroke burden.

The Vietnamese government has been increasing healthcare expenditure and gradually expanding universal health insurance coverage to improve access to specialized care, including neurological and interventional services. Public hospitals now receive higher budgets to procure advanced medical equipment, including neurovascular catheters, embolic coils, flow diverters, and imaging systems. Partial or full reimbursement of neurovascular interventions under the Vietnam Social Security (VSS) system reduces the out-of-pocket burden for patients, increasing affordability and procedural volume. Improved financial accessibility translates into higher procedure throughput and more stable procurement cycles for suppliers, encouraging broader market participation and device portfolio expansion. The government has initiated several infrastructure enhancement programs including the “Master Plan for Health Facility Development” focused on upgrading tertiary and provincial hospitals to manage advanced medical conditions such as stroke, aneurysm, and cerebral artery disease. Many hospitals are being equipped with catheterization labs, neuroimaging units, and hybrid operating rooms, which are critical for deploying neurovascular devices. These initiatives are not limited to large cities; regional and provincial centers are now receiving funding and equipment to offer interventional neurology services. This decentralization of care increases regional penetration for device suppliers, allowing companies to move beyond Tier 1 markets and tap into underpenetrated provinces with rising demand.

Download Free Sample Report

Key Market Challenges

Limited Access to Advanced Neurointerventional Care Outside Major Cities

Despite the growth of healthcare infrastructure in urban areas, access to neurovascular intervention remains highly centralized, with specialized stroke treatment and endovascular procedures largely confined to major cities such as Ho Chi Minh City and Hanoi.

Patients in rural or remote regions face long travel distances and treatment delays, reducing the effectiveness of time-sensitive stroke interventions such as mechanical thrombectomy. Regional and district hospitals often lack trained interventional neuroradiologists, modern catheterization labs, and real-time imaging systems, limiting their ability to offer advanced procedures. The concentration of neurovascular treatment in a few urban hubs restricts the geographical expansion of the market.

Until comprehensive care networks and telemedicine-based referral systems are developed, market opportunities will remain concentrated, preventing the broader distribution of neurovascular devices across the country.

High Cost of Neurovascular Devices and Inadequate Insurance Coverage

Advanced neurovascular devices such as flow diverters, stent retrievers, and detachable coils come with high procurement and procedural costs, which pose a significant barrier in a cost-sensitive market like Vietnam. Many hospitals, especially in the public sector, operate under tight budget constraints and often rely on older or more basic technologies. For patients, out-of-pocket spending remains substantial as national health insurance schemes do not always fully reimburse high-end neurointerventional procedures. This cost barrier discourages early adoption and limits private sector investment in premium neurovascular solutions.

Device manufacturers and distributors must navigate a pricing-sensitive environment and may need to offer cost-optimized portfolios, value-based pricing models, or partnerships with government programs to drive broader adoption.

Key Market Trends

Expansion of Specialized Neurointerventional Infrastructure

Vietnam is witnessing major investments in healthcare infrastructure particularly in urban hubs such as Ho Chi Minh City, Hanoi, and Da Nang where hospitals are being equipped with specialized departments for neurology, neurosurgery, and interventional radiology.

Public-private partnerships are accelerating the modernization of catheterization labs and imaging centers. Tertiary and quaternary care hospitals are actively expanding their inventory of neurovascular devices to meet procedural demands. Training initiatives and physician workshops are improving the clinical adoption of advanced techniques like coil embolization, flow diversion, and balloon angioplasty.

This infrastructure development will enable wider access to neurointerventional care beyond major cities, increasing the penetration of neurovascular devices in Tier 2 and Tier 3 markets, thereby broadening market reach and boosting volume growth.

Increasing Adoption of Minimally Invasive Technologies and Innovation-Driven Procurement

There is a strong shift in Vietnam's neurosurgical community toward minimally invasive, image-guided procedures that reduce hospital stays, minimize surgical trauma, and improve patient outcomes. The adoption of next-generation neurovascular devices such as detachable coils, liquid embolics, flow diverters, and microcatheters is gaining momentum. Global medical device manufacturers are expanding their presence in Vietnam, offering tailored product portfolios and after-sales support, which is enhancing technology uptake. Competitive pricing, training support, and local distributor partnerships are helping in deeper market penetration of sophisticated devices.

Technological innovation will remain a core growth pillar. As Vietnamese hospitals seek to align with international best practices and improve patient care standards, procurement of advanced neurovascular solutions will rise substantially.

Segmental Insights

Therapeutic Application Insights

Based on the category of Therapeutic Application, the Stroke segment emerged as the fastest growing segment in the Vietnam Neurovascular Devices Market in 2024. Vietnam is witnessing a surge in stroke cases, particularly ischemic strokes, due to an increase in sedentary lifestyles, hypertension, diabetes, smoking, and poor diet. According to local health authorities, stroke has become one of the leading causes of death and disability, prompting urgent healthcare responses and driving the rapid adoption of stroke management devices such as stent retrievers, thrombectomy catheters, and balloon guide catheters.

The introduction and rapid diffusion of mechanical thrombectomy and clot aspiration systems in Vietnamese hospitals have revolutionized stroke care. These minimally invasive procedures offer faster recovery times and improved patient outcomes, making them highly attractive to both clinicians and healthcare administrators. As tertiary care centers and stroke-ready hospitals increase in number, the demand for these devices is expanding at an accelerated pace. The Vietnamese Ministry of Health is actively promoting early stroke detection and response protocols across regional hospitals. The development of stroke centers and the integration of national stroke management guidelines are fostering increased procurement of neurovascular devices specifically designed for stroke intervention. These factors are expected to drive the growth of this segment.

Download Free Sample Report

Regional Insights

Southern Vietnam emerged as the largest market in the Vietnam Neurovascular Devices Market in 2024, holding the largest market share in terms of value. Southern Vietnam, particularly Ho Chi Minh City, is home to several high-capacity tertiary care hospitals such as Cho Ray Hospital, FV Hospital, and the University Medical Center. These facilities are well-equipped with state-of-the-art neurovascular imaging and intervention technologies, making them key consumers of advanced neurovascular devices such as stent retrievers, embolic coils, and clot aspiration systems.

Southern Vietnam attracts a high volume of complex neurovascular cases, not only from within the region but also from neighboring provinces and parts of Central Vietnam. Patients often travel to Ho Chi Minh City seeking specialized stroke treatment and neurosurgical interventions, creating sustained demand for neurovascular technologies. The region sees robust participation from private hospitals and diagnostic centers, which actively invest in the latest medical devices and minimally invasive solutions. These facilities cater to both domestic and international patients, thereby fostering greater market adoption of innovative neurovascular solutions.

Recent Developments

• In June 2025- The establishment of the Preclinical Research Center (Animal Lab) represents a strategic milestone in advancing Vietnam’s capabilities in both medical equipment development and neurovascular intervention training. This facility is set to play a critical role in supporting the domestic design, testing, and production of medical devices, while also serving as a national hub for hands-on clinical training. Beyond its regional significance in the Mekong Delta, the center is expected to catalyze broader innovation in medical research and practical education across Vietnam’s healthcare system.   

Key Market Players

• Stryker
• Johnson & Johnson Services, Inc.
• Medtronic
• Terumo Vietnam Co., Ltd.
• Penumbra, Inc.

Report Scope:

In this report, the Vietnam Neurovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vietnam Neurovascular Devices Market, By Device:

o   Cerebral Embolization and Aneurysm Coiling Devices

o   Cerebral Angioplasty and Stenting Systems

o   Neurothrombectomy Devices

o   Support Devices

o   Trans Radial Access Devices

• Vietnam Neurovascular Devices Market, By Therapeutic Application:

o   Stroke

o   Cerebral Artery

o   Cerebral Aneurysm

o   Others

• Vietnam Neurovascular Devices Market, By End User:

o   Hospitals

o   Specialty Clinics

o   Others

• Vietnam Neurovascular Devices Market, By Region:

o   Northern Vietnam

o   Central Vietnam

o   Southern Vietnam

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Vietnam Neurovascular Devices Market.

Available Customizations:

 Vietnam Neurovascular Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).